Well tolerated in adults with ADHD, aged 18 to 65 years

In controlled clinical trials, fewer than 6% of adults discontinued taking CONCERTA^® due to adverse events. In addition to the results here, trials also showed CONCERTA^® had no clinically relevant effect on vital signs for up to one year.

 

Adverse reactions Reported by >1% of CONCERTA®-Treated Adult Patients in 2 Placebo-Controlled, Double-Blind Clinical Trials*
*included doses up to 108 mg.
The majority of ADRs were mild to moderate in severity.